Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists

Bioorg Med Chem. 2008 Nov 1;16(21):9524-35. doi: 10.1016/j.bmc.2008.09.039. Epub 2008 Sep 17.

Abstract

The present work describes the discovery of novel series of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepine-5-ylidene)acetamide derivatives as arginine vasopressin (AVP) V(2) receptor agonists. By replacing the amide juncture in YM-35278 with a direct ring connection gave compound 10a, which acts as a V(2) receptor agonist. These studies provided the potent, orally active non-peptidic V(2) receptor agonists 10a and 10j.

MeSH terms

  • Animals
  • Antidiuretic Agents / chemical synthesis
  • Antidiuretic Agents / chemistry
  • Antidiuretic Agents / pharmacology
  • Arginine Vasopressin / metabolism*
  • Benzazepines / chemical synthesis*
  • Benzazepines / chemistry
  • Benzazepines / pharmacology
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Male
  • Molecular Structure
  • Radioligand Assay
  • Rats
  • Rats, Wistar
  • Receptors, Vasopressin / agonists*
  • Receptors, Vasopressin / metabolism
  • Structure-Activity Relationship

Substances

  • Antidiuretic Agents
  • Benzazepines
  • Receptors, Vasopressin
  • Arginine Vasopressin